Literature DB >> 27354595

Photodynamic Therapy Potentiates the Effects of Curcumin on Pediatric Epithelial Liver Tumor Cells.

Verena Ellerkamp1, Nicola Bortel2, Evi Schmid2, Bettina Kirchner2, Sorin Armeanu-Ebinger2, Jörg Fuchs2.   

Abstract

BACKGROUND/AIM: Curcumin (CUM) is a promising agent in complementary oncology. The present study analyzed the photoactive properties of curcumin on pediatric epithelial liver tumor cell lines.
MATERIALS AND METHODS: Hepatoblastoma cell lines (HuH6, HepT1) and hepatocellular carcinoma cell lines (HepG2, HC-AFW1) were treated with curcumin and exposed to blue light (phototherapy, 480 nm, 300 W). Cell viability (MTT tests), cellular oxidative stress (production of reactive oxygen species (ROS)) and cellular uptake/degradation of curcumin were analyzed.
RESULTS: Significant loss of viability resulted from 24-48 h incubation with curcumin. With photodynamic therapy (PDT), even short time incubation (1 h) with curcumin resulted in significantly lower half maximal inhibitory concentration (IC50) (p<0.001, two-way ANOVA). Significant ROS production was observed with PDT and curcumin.
CONCLUSION: Phototherapy strongly enhances the anticancer properties of curcumin in pediatric solid liver tumors in vitro. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Curcumin; hepatocellular carcinoma; heptoblastoma; photodynamic therapy

Mesh:

Substances:

Year:  2016        PMID: 27354595

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Comparing deep eutectic solvents and cyclodextrin complexes as curcumin vehicles for blue-light antimicrobial photodynamic therapy approaches.

Authors:  Eduardo Silva; Ivo M Aroso; Joana M Silva; Rui L Reis
Journal:  Photochem Photobiol Sci       Date:  2022-04-02       Impact factor: 4.328

2.  The comparative effects of Resveratrol and Curcumin in combination with photodynamic therapy.

Authors:  István-Péter Laszló; Mihaela Ramona Laszló; Tiberiu Popescu; Vlad Toma; Rodica Mariana Ion; Remus Moldovan; Gabriela Adriana Filip; Calin Cainap; Simona Clichici; Adriana Muresan
Journal:  Med Pharm Rep       Date:  2022-04-28

3.  Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway.

Authors:  Ji Wang; Chunying Wang; Gaofeng Bu
Journal:  Exp Ther Med       Date:  2018-01-29       Impact factor: 2.447

Review 4.  Application of photodynamic therapy for liver malignancies.

Authors:  Heng Zou; Fusheng Wang; Jiang-Jiao Zhou; Xi Liu; Qing He; Cong Wang; Yan-Wen Zheng; Yu Wen; Li Xiong
Journal:  J Gastrointest Oncol       Date:  2020-04

5.  Low Dosed Curcumin Combined with Visible Light Exposure Inhibits Renal Cell Carcinoma Metastatic Behavior In Vitro.

Authors:  Jochen Rutz; Sebastian Maxeiner; Saira Justin; Beatrice Bachmeier; August Bernd; Stefan Kippenberger; Nadja Zöller; Felix K-H Chun; Roman A Blaheta
Journal:  Cancers (Basel)       Date:  2020-01-28       Impact factor: 6.639

Review 6.  Targeted Nanomaterials for Phototherapy.

Authors:  Upendra Chitgupi; Yiru Qin; Jonathan F Lovell
Journal:  Nanotheranostics       Date:  2017-01-01

7.  EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles.

Authors:  Wen-Hsuan Tsai; Kun-Hua Yu; Yi-Cheng Huang; Cheng-I Lee
Journal:  Int J Nanomedicine       Date:  2018-02-09

8.  Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line.

Authors:  Amr Ehab Kamel; Maha Fadel; Dina Louis
Journal:  Int J Nanomedicine       Date:  2019-07-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.